1. Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal meet. Clin Gastroenterol Hepatol. 2020;18(4):767–76.
2. Armstrong D. Potassium-competitive acid blockers and gastroesophageal reflux disease. Gastroenterol Hepatol. 2023;19(5):295–8.
3. Onconic Therapeutics. Onconic Therapeutics receives MFDS approval for JAQBO, a new treatment for gastroesophageal reflux disease (GERD) [media release]. 25 Apr 2024. https://www.prnewswire.com/in/news-releases/onconic-therapeutics-receives-mfds-approval-for-jaqbo-a-new-treatment-for-gastroesophageal-reflux-disease-gerd-302127478.html.
4. Onconic Therapeutics. JAQBO 20 mg tablets (zastaprazan citrate): Korean prescribing information. 2024.
5. Livzon Pharmaceuticals. Voluntary announcement entering into the license agreement [media release]. 10 Mar 2023. http://www1.hkexnews.hk.